Techne Corp (NASDAQ:TECH)

CAPS Rating: 5 out of 5

The Company and its subsidiaries are engaged in the development and manufacture of biotechnology products and hematology calibrators and controls.

Recs

0
Player Avatar Lants (< 20) Submitted: 7/28/2011 7:52:13 PM : Outperform Start Price: $74.63 TECH Score: -9.90

Sales have grown steadily while the cost of sales has decreased. Revenue and earnings have also increased over the past two years.

Featured Broker Partners


Advertisement